Global OTC Reach Pharma Nobis serves over 45,000 pharmacies and distributes more than 160 OTC and pharmaceutical items across major drug, food, and mass-market retail chains, indicating broad retail channel access for potential product placements, co-promotions, and expanded distribution partnerships.

FDA compliant Ops Operating with state-of-the-art FDA registered, cGMP compliant facilities, the company demonstrates strong quality infrastructure, making it suitable for scalable manufacturing partnerships, contract manufacturing opportunities, and high-standard product launches.

Global Footprint Presence in approximately 20 countries suggests potential for cross-border distribution collaborations, regional regulatory support, and multi-market pilots for new therapies or OTC lines targeting diverse geographies.

Mid-scale Revenue With annual revenue in the 50 to 100 million USD range and a workforce of 51-200, there is appetite for strategic partnerships in midsize pharma segments, including co-development, contract manufacturing, and joint market access initiatives.

Strategic Focus Diversified portfolio spanning innovative pharmaceuticals and consumer OTC products implies opportunities for line extensions, category adjacencies, and co-branding with existing OTC platforms to accelerate go-to-market timelines.